# FDA 483 - Richard E. Ringel, M.D. - December 17, 2015

Source: https://www.globalkeysolutions.net/records/483/richard-e-ringel-md/9d7e6053-24c3-42c0-8707-0626d05a0d5d

> FDA 483 for Richard E. Ringel, M.D. on December 17, 2015. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Richard E. Ringel, M.D.
- Inspection Date: 2015-12-17
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - East II
- Summary: An FDA inspection of Richard E. Ringel, M.D. in Baltimore, MD, from December 14-17, 2015, revealed significant deviations from an investigational plan and study protocol. The firm failed to properly record adverse events for study subjects and did not maintain adequate subject accountability, including follow-up for missed visits and documentation for subjects lost to follow-up. These findings indicate serious issues in the conduct and oversight of clinical investigations.

## Related Documents

- [483 - 2009-02-03](https://www.globalkeysolutions.net/records/483/richard-e-ringel-md/af11fdda-e549-4600-9c93-814383e1d56f)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/cynthia-a-harris/4eddc52f-e8f8-40e6-a233-5b6d1768b482)

Company: https://www.globalkeysolutions.net/companies/richard-e-ringel-md/f3011391-1f5b-4a50-b55b-11e1d1e8b091

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-east-ii/a9ab7e08-db36-4350-a7d7-6a61dc61250e